Nomura Holdings
MDGL icon

Nomura Holdings’s Madrigal Pharmaceuticals MDGL Stock Holding History

Nomura Holdings’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,500
Closed -$8.44M – 1957
2025
Q4 		$8.44M Buy
14,500
+4,300
+42% +$2.2M 0.01% 596
2025
Q3 		$4.68M Buy
10,200
+2,100
+26% +$783K 0.01% 806
2025
Q2 		$2.45M Buy
+8,100
New +$2.41M 0.01% 786
2025
Q1 		– Sell
-8,800
Closed -$2.72M – 2122
2024
Q4 		$2.72M Buy
8,800
+2,800
+47% +$788K ﹤0.01% 991
2024
Q3 		$1.27M Sell
6,000
-1,000
-14% -$256K ﹤0.01% 1080
2024
Q2 		$1.96M Buy
+7,000
New +$1.67M ﹤0.01% 950

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nomura Holdings's MDGL Position: Q2 2025 in Review

Nomura Holdings sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2025, closing a stake of 1,692 shares — an estimated $504K sold.

Nomura Holdings first reported a position in MDGL in Q2 2013 and held it in 14 quarters. The position peaked at $2.91M in Q2 2019. 305 funds tracked by Wall St. Rank hold MDGL as of Q2 2025.

  • Nomura Holdings reported no remaining Madrigal Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Nomura Holdings sold 1,692 Madrigal Pharmaceuticals shares in Q2 2025, an estimated $504K.
  • Nomura Holdings first reported a position in Madrigal Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • Nomura Holdings's Madrigal Pharmaceuticals position peaked at $2.91M in Q2 2019.
  • 305 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2025.

Based on Nomura Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.